CLINICAL_TRIALS
trial_result
· 2013-07-19
Clinical Trial Update: A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis [Phase 1]
Summary
A Phase 1 safety and tolerability study of PUR118 in subjects with cystic fibrosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pulmatrix Inc. | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED